GENEVA, Sept. 22 -- UNICYCIVE THERAPEUTICS, INC. (4300 El Camino Real, Suite 210Los Altos, California 94022) filed a patent application (PCT/US2025/020037) for "PYRIDINE MODIFIED NICORANDIL DERIVATIVES" on Mar 14, 2025. With publication no. WO/2025/194102, the details related to the patent application was published on Sep 18, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): RAI, Roopa (c/o Unicycive Therapeutics, Inc.4300 El Camino Real, Suite 210Altos, California 94022)
Abstract:
The present disclosure is directed to Nicorandil derivative compounds, pharmaceutical compositions thereof, an...